These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28420583)

  • 1. Diabetes medication persistence, different medications have different persistence rates.
    Shani M; Lustman A; Vinker S
    Prim Care Diabetes; 2017 Aug; 11(4):360-364. PubMed ID: 28420583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to oral antihypertensive medications, are all medications equal?
    Shani M; Lustman A; Vinker S
    J Clin Hypertens (Greenwich); 2019 Feb; 21(2):243-248. PubMed ID: 30734469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction.
    Arnold SV; Spertus JA; Masoudi FA; Daugherty SL; Maddox TM; Li Y; Dodson JA; Chan PS
    J Am Coll Cardiol; 2013 Nov; 62(19):1791-801. PubMed ID: 23973701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Care trajectories are associated with quality improvement in the treatment of patients with uncontrolled type 2 diabetes: A registry based cohort study.
    Goderis G; Van Casteren V; Declercq E; Bossuyt N; Van Den Broeke C; Vanthomme K; Moreels S; Nobels F; Mathieu C; Buntinx F
    Prim Care Diabetes; 2015 Oct; 9(5):354-61. PubMed ID: 25709079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study).
    Hermans M; Van Gaal L; Rézette I; Daci E; MacDonald K; Denhaerynck K; Vancayzeele S; De Meester L; Clemens A; Yee B; Abraham I
    Prim Care Diabetes; 2016 Dec; 10(6):425-433. PubMed ID: 27388795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of adherence to anti-diabetic medications among type 2 diabetic patients in a Sudanese outpatient clinic.
    Mirghani HO
    Pan Afr Med J; 2019; 34():34. PubMed ID: 31762902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refill adherence to oral hypoglycemic agents and glycemic control in veterans.
    Kim N; Agostini JV; Justice AC
    Ann Pharmacother; 2010 May; 44(5):800-8. PubMed ID: 20388863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).
    Duru OK; Turk N; Ettner SL; Neugebauer R; Moin T; Li J; Kimbro L; Chan C; Luchs RH; Keckhafer AM; Kirvan A; Ho S; Mangione CM
    J Gen Intern Med; 2015 Nov; 30(11):1645-50. PubMed ID: 25944019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.
    Calip GS; Hubbard RA; Stergachis A; Malone KE; Gralow JR; Boudreau DM
    Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):75-85. PubMed ID: 24923811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.
    Fadini GP; Frison V; Simioni N; Lapolla A; Gatti A; Bossi AC; Del Buono A; Fornengo P; Gottardo L; Laudato M; Perseghin G; Bonora E; Avogaro A
    J Am Heart Assoc; 2019 Jul; 8(14):e012244. PubMed ID: 31269877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician-specific variation in medication adherence among diabetes patients.
    Sherman BW; Sekili A; Prakash ST; Rausch CA
    Am J Manag Care; 2011 Nov; 17(11):729-36. PubMed ID: 22084892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.
    Adamek KE; Ramadurai D; Gunzburger E; Plomondon ME; Ho PM; Raghavan S
    J Am Heart Assoc; 2019 Feb; 8(3):e011448. PubMed ID: 30712488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
    Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD;
    Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence and factors associated with poor adherence among type 2 diabetes mellitus patients on follow-up at Kenyatta National Hospital, Kenya.
    Waari G; Mutai J; Gikunju J
    Pan Afr Med J; 2018; 29():82. PubMed ID: 29875963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers: New-onset diabetes mellitus stratified by statin use.
    Shin J; Kim H; Yim HW; Kim JH; Lee S; Kim HS
    J Clin Pharm Ther; 2022 Jan; 47(1):97-103. PubMed ID: 34668200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus.
    Wu H; Liu J; Lou Q; Liu J; Shen L; Zhang M; Lv X; Gu M; Guo X
    Medicine (Baltimore); 2017 Sep; 96(35):e7533. PubMed ID: 28858080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.